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Executive Summary  
 
  A key determinant of the fate of the Environmental Protection Agency’s (EPA) 
1997 ozone standard is how the Agency responds to a Court of Appeals’ decision that it 
must consider not only harmful respiratory effects, but also ozone’s beneficial ability to 
reduce exposure to harmful ultraviolet radiation (UV-B). 
In January 2001, EPA Administrator Browner signed a proposed response to the 
Court of Appeals’ decision, but it has several problems.  EPA’s Scientific Advisory 
Committee did not review the scientific basis for Browner’s proposed response, although 
such review is required by statute and EPA’s internal procedures.  The proposed response 
also ignores earlier EPA analysis suggesting that the health benefits of ozone are n ot 
negligible. Finally, it has significant conceptual flaws that the Advisory Committee could 
have corrected.   
The existence of a tradeoff between respiratory effects and UV-B related risks 
means that careful science is essential to ensure that air quality standards improve public 
health. Before publishing a proposed response to the Court’s decision, EPA should 
submit its assessments of UV-B related risks to its Scientific Advisory Committee. It 
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1. Introduction  
 
A key determinant of the fate of the Environmental Protection Agency’s (EPA) 
1997 ozone standard is how the Agency responds to a Court of Appeals’ decision that it 
must consider not only harmful respiratory effects, but also ozone’s beneficial ability to 
reduce exposure to ultraviolet radiation (UV-B), which causes skin cancers and 
cataracts.
1 While these benefits are smaller than the UV-B screening benefits of 
stratospheric ozone that have motivated stringent regulatory actions on a global scale, 
they may be significant relative to the modest respiratory benefits of EPA’s 1997 ozone 
standard.
2  
On January 19, 2001, then-EPA Administrator Browner signed a proposed 
response to the Court of Appeals remand, hereinafter referred to as the Response.
3 The 
Response states that information linking changes in ground level ozone concentrations to 
changes in exposures to UV-B radiation is too uncertain to warrant relaxing the standard 
issued in 1997. It also says associated changes in UV-B radiation exposures would likely 
be very small from a public health perspective. It then embraces the seemingly 
inconsistent conclusions that the benefits of tropospheric ozone effects are both 
“unquantifiable” and “small.”
4 Finally it reproposes an ozone standard identical to the 
one promulgated in 1997.
5 The new Administration has prevented publication of the 
Response, and EPA Administrator Whitman has yet to decide how to proceed.
6  
                                                 
1 See U. S. Court of Appeals for the District of Columbia Circuit (1999). In setting the original 1997 
standard, EPA had taken the position that only adverse effects should be considered.  See Lutter and Wolz 
(1997) and U.S. Department of Energy (1995) for a discussion of the evidence and further readings.  
2 See Lutter and Wolz (1997).  See Graham and Weiner (1995) for a summary of other risk-risk tradeoffs 
and the government’s management of risk in this context.  
3 See U.S. Environmental Protection Agency (2001).  
4 See U.S. Environmental Protection Agency (2001, p.100). 
5 See U.S. Environmental Protection Agency (2001). 




The Clean Air Act accords a key role to science and scientific advisory bodies in 
the development of air quality standards. The Act establishes a committee, EPA’s Clean 
Air Scientific Advisory Committee (CASAC), to “assist in the development of air quality 
criteria.”
7 This Committee reviews a “Criteria Document,” which, according to the Clean 
Air Act, must “accurately reflect the latest scientific knowledge useful in indicating the 
kind and extent of all identifiable effects on public health or welfare which may be 
expected from the presence of such pollutant in the ambient air [emphasis added].”
8 The 
Clean Air Act directs EPA to issue air quality standards, which, “in the judgment of the 
Administrator, based on such criteria and allowing an adequate margin of safety, are 
requisite to protect the public health [emphasis added].”
9   
Historically, EPA has extended scientific review beyond the minimum legal 
requirements. For example, EPA asked CASAC to review a “Staff Paper,” which 
translates the science in the Criteria Document into terms useful to policy makers.
10 To 
supplement CASAC’s work, EPA asked the scientific community, interested parties and 
the general public to comment on both documents.
11 
We show here that the Response has an inadequate scientific basis that could 
expose the ozone standard to further legal challenges. The Response argues that 
reproposal of the 1997 standard is appropriate given the existing administrative record 
and that reopening the record to allow CASAC review of UV-B related health effects is 
unnecessary.
12 But EPA’s 1996 air quality Criteria Document, on which the standard 
must be “based,”
13 has no discussion of UV-B related health effects.   
We also identify several concerns that, in the absence of CASAC review, raise 
doubts about whether the respiratory health improvements outweigh UV-B related health 
effects. The Response states that UV-B related health effects are small without 
comparing estimates of such effects with the respiratory health benefits of the ozone 
standard. It dismisses UV-B related effects as unquantifiable without identifying a 
                                                 
7 See Clean Air Act Section 117 and also Section 109(d)(2).   
8 See Clean Air Act Section 108(a)(2).    
9 See Clean Air Act Section 109(b)(1). 
10 See Clean Air Scientific Advisory Committee (1995b and 1995c).  See also Clean Air Scientific 
Advisory Committee (1995a). 
11 See U.S. Environmental Protection Agency (1997c). 
12 See U.S. Environmental Protection Agency (2001). 




threshold level of uncertainty necessary for this conclusion. It also makes highly selective 
use of available information and analyses without providing any justification. 
In sum, the Response sets an unwise precedent for EPA to act without assurances 
that its actions are based on a strong scientific foundation as recommended by the 
National Academies of Science.
14 This is particularly true given the increased importance 
of careful science apparent in the Supreme Court’s recent interpretation of the Act. The 
Court confirmed EPA’s longstanding contention that it could not consider costs in setting 
air quality standards. But it added that this section of the Act requires “EPA to set air 
quality standards at the level that is ‘requisite’—that is, not lower or higher than is 
necessary—to protect the public health with an adequate margin of safety.”
15 Even 
without tradeoffs between skin cancers and respiratory function, EPA will need a careful 
risk assessment in order to set a standard that meets this criterion.   
  The next two sections address issues of process and substance respectively. The 
final section outlines our recommendations.  
 
2. Procedural Problems  
    In its May 1999 American Trucking Associations decision, the U.S. Court of 
Appeals for the D.C. Circuit ruled that “EPA must consider positive identifiable effects 
of a pollutant’s presence in the ambient air in formulating air quality criteria under 
section 108 and national ambient air quality standards under section 109 [emphasis 
added].”
16   
EPA’s Response to this decision seems inconsistent with provisions of the Clean 
Air Act. A key question is whether EPA’s air quality criteria, on which standards must be 
“based,”
17 already “accurately reflect”
18 knowledge useful in indicating beneficial UV-B 
related effects of ozone. The Response argues that the existing criteria are sufficient and 
that reopening the administrative record is unnecessary because EPA recognized in 1997 
                                                 
14 See National Research Council (2000). 
15 See U.S. Supreme Court (2001, p. 15). 
16 See U.S. Court of Appeals (1999, p. 25).  The Administration did not seek Supreme Court review of this 
ruling.  
17  See Clean Air Act Section 109(b)(1). 




that tropospheric ozone absorbs UV-B radiation.
19 In support of this claim the Response 
cites a partial paragraph
20 in the three-volume Criteria Document. But the two sentences 
are silent about health effects. Obviously, the existing Criteria Document falls well short 
of the Act’s mandate to “accurately reflect the latest scientific knowledge.”
21 
The inadequacy of the Criteria Document results from CASAC’s truncated review 
of the UV-B question. At a March 1995 public meeting, Dr. Marvin Frazier of the 
Department of Energy presented to CASAC an analysis suggesting that UV-B related 
health effects associated with a 10 parts-per-billion reduction in tropospheric ozone could 
total dozens of deaths, thousands of non-melanoma skin cancers, and tens of thousands of 
cataracts.
 22 Following the presentation, one CASAC member asked about governmental 
mechanisms for looking at this issue in a comprehensive fashion and the argument for 
having this information factored into  the Criteria Document, as perhaps distinct from 
having the information available in some other form. He then posed the key question: 
“Should this group [CASAC] take responsibility for this problem?”
23  EPA staff replied, 
“We do not think . . . that the health effects of UV-B have to be added to the Criteria 
Document.”
24 EPA staff also noted that there was as yet no decision on the separate 
policy question of whether UV-B health effects should be used to set the standards.
25 
Based on this advice from EPA staff, the 1996 Criteria Document excluded both Dr. 
Frazier’s assessment of UV-related health risks and CASAC’s views about how to 
incorporate such risk estimates into the standard-setting process.   
  A second major procedural problem with the Response is its complete neglect of 
an earlier EPA analysis. It does not cite a 1997 EPA assessment of UV-B related health 
effects that was given to the Office of Management and Budget and is available in its 
docket. This assessment states “Any decrease in atmospheric ozone causes an increase in 
                                                 
19  See U.S. Environmental Protection Agency (2001, p.21). 
20 See U.S. Environmental Protection Agency (1996a, p. 5-79).  The entire discussion is “However, the 
intensity of UV-B radiation reaching the earth’s surface may be attenuated by O3-pollution in the lower 
troposphere (Brühl and Crutzen, 1989). Differences in the degree of this attenuation probably contribute to 
the discrepancies between recently observed trends in surface-level UV-B intensities (Scotto et al., 1988; 
Blumenthaler and Ambach, 1990).” 
21  See Clean Air Act Section 108(a)(2). 
22 See Lutter and Wolz (1997) for a readily available summary of Dr. Frazier’s estimates. 
23 See U.S. Environmental Protection Agency, (1995, p. p. 212). 
24 See U.S. Environmental Protection Agency, (1995, p. 217). 




solar radiation incident at the Earth’s surface and therefore an increase in the incidence of 
non-melanoma skin cancers under the assumption that all other pertinent factors are held 
constant. The methodology for estimating such increases (of both UV levels and skin 
cancer incidence) is well-established.”
26 The study concludes that 696 cases of non-
melanoma skin cancers would result each year from the changes in ozone concentration 
that it modeled, but the Response fails to mention this work. 
The 1997 EPA assessment goes beyond earlier work by Cupitt (1994), Frazier 
(1995), and Lutter and Wolz (1997), who had assessed changes in UV-B and associated 
skin cancers and cataracts based on an assumed uniform decline of 10 parts per billion in 
seasonal average ozone concentrations. The 1997 research assessed health effects for a 
change in ozone concentrations between a state-specific baseline and full attainment of 
EPA’s proposed standard including changes in UV-B exposure at one-hour intervals 
throughout daylight hours.
27   
EPA has not refined its 1997 assessment, although a quick review suggests three 
areas for improvements. First, the analysis assumes a “current baseline” which is likely to 
result in an overstatement of adverse UV-B related health effects resulting from the 
standard to the extent that ozone concentrations would decline even in the absence of the 
new standard as areas approach attainment with the pre-existing ozone standard. Second, 
the analysis assumes that the entire population of each state experiences changes in ozone 
concentration that reflect a state-wide average. Since most people reside in major 
metropolitan areas where ozone concentrations exceed the statewide average, this 
approach will understate the average change in ozone concentration experienced by U.S. 
residents under the new standard. Third, the study is silent on other UV-B related health 
effects, though these may collectively be more important. Making these improvements is 
important because they could either raise or lower estimated benefits.  
Finally, the Response departs from established procedures in deciding not to 
quantify UV-B related health effects without first seeking CASAC’s advice. Earlier, in 
assessing possible reductions in mortality risk from reduced ozone concentrations, EPA 
                                                 
26 See U.S. Environmental Protection Agency (1997a, p. 1). 




based its decision not to develop quantitative estimates on advice from CASAC.
28 The 
1996 Criteria Document concluded the association between ozone and mortality needed 
further investigation.
29 In contrast, the Response left UV-B  related health risks 
unquantified without any advice from CASAC.  
 
3. Substantive Problems  
  There are substantive problems with the Response, in addition to the procedural 
concerns outlined above. First, there is an internal inconsistency in its determination that 
information linking tropospheric ozone to UV-B related health effects is too uncertain to 
warrant relaxation of the standard. The Response justifies this conclusion in part by 
stating, “associated changes in UV-B radiation exposures of concern would likely be very 
small from a public health perspective.”
30 Yet this conclusion appears inconsistent with 
its view that UV-B related effects on public health are unquantifiable. The Response even 
states at one point that UV-B related health effects are “are likely very small, albeit 
unquantifiable.”
31  The Response begs the question how one can conclude something is 
small without measuring it quantitatively.  
Second, notwithstanding the statement in the 1997 paper that the methodology for 
quantification of health risks is “well established,” the Response concludes that UV-B 
related health effects are unquantifiable. It is impossible, however, to judge the scientific 
merit of that conclusion because the Response does not identify a threshold level of 
uncertainty above which effects would be unquantifiable. Moreover, it is unclear whether 
the uncertainty associated with UV-B related effects will be smaller than uncertainty 
associated with other effects that EPA has quantified. In other contexts EPA has 
quantified risks that are very uncertain. For example, in a recent drinking water 
regulation addressing cancer risks from disinfection byproducts, EPA reported that the 
                                                 
28 EPA did develop quantitative estimates of mortality effects of ozone for use in its benefit-cost analysis.  
It based these in part on research that became available after CASAC concluded its review of the Criteria 
Document.  But these were on the other side of the firewall separating EPA’s economic analysis from its 
decision-making.  See U.S. Environmental Protection Agency (1997b and 1997d).   
29 See U.S. Environmental Protection Agency (1996a, p. 7-161). 
30 See U.S. Environmental Protection Agency (2001, p. 2). 




baseline risks varied from 1 to 10,000 cases of cancer per year.
32  The Response’s 
conclusion that the benefits cannot be quantified is difficult to understand. 
Third, EPA’s conclusion that the benefits of ozone are small is not based on any 
comparison of these benefits with estimates of the respiratory health benefits from the 
1997 standard. Yet from the perspective of protecting public health, this is the only 
sensible basis by which to judge size.  
The Response acknowledges that many of the factors important in conducting an 
assessment of UV-B related effects in a given area are also important in the assessment of 
respiratory health effects.
33  These factors cannot therefore provide an explanation of why 
respiratory effects, but not UV-related effects, can be quantified. In search of such an 
explanation, the Response states: “While analogous to the r espiratory-related factors, 
there are a number of important differences between these sets of factors that arise.”
34 
Yet for the four such differences that it lists, it provides no persuasive reasons why they 
are sufficient to prevent quantification of health effects related to UV-B but not to 
respiratory function. Two of these differences—whether the health effects are “direct” 
(related to respiration) or “indirect” (related to solar radiation) and whether they derive 
from dermal or inhalation exposures—are by themselves irrelevant to determining the 
magnitude and uncertainty of risks. Another—whether effects vary with skin color—is 
also irrelevant. Skin color is no different from other demographic variables like age, level 
of physical activity and health status that EPA already considers in its risk assessments. 
The fourth difference, that quantifiable respiratory health effects stem from short-term 
exposures while UV-B related health effects result from chronic exposures would affect 
the form of a health-based air quality standard, but not whether UV-B related health 
effects can be quantified.
35  
                                                 
32 See U.S. Environmental Protection Agency (1998).   
33 See U.S. Environmental Protection Agency (2001, p. 76). 
34 See U.S. Environmental Protection Agency (2001, p. 77). 
35 Note that EPA’s rationale for the standard includes concern about unquantified “possible long-term 
damage to the lungs.”  See U.S. Environmental Protection Agency (1997c, p. 38856).  Estimates of chronic 
health effects depend on assumptions about how emissions-related declines in ozone concentrations vary 
with weather patterns and times of the day or season.  In its assessments of respiratory risks EPA already 
addresses these variations by assuming ozone concentrations “rollback” as the standard becomes more 




Almost all of the sources of uncertainty in UV-B related health effects mirror 
similar sources of uncertainty in respiratory health effects. For example, aerosols affect 
UV-B screening by low-level ozone, and air pollutants may also modify the effects of 
ozone on human respiration.
36  One exception, the effects of a more stringent standard on 
the column of ozone above the ground, is not the subject of serious discussion in the 
Response.
37  The Response seems to deviate from the D.C. Circuit’s instructions that 
EPA evaluate health benefits using the “same approach” as it does for reviewing studies 
showing benefits from ozone reductions.
38  It imposes a higher hurdle for quantifying 
UV-B related effects than respiratory effects.  
EPA’s 1997 analysis, which the Response ignores, suggests that benefits of ozone 
may be significant relative to the respiratory health benefits of the ozone standard. To 
illustrate, we assume for simplicity that the ratio of non-melanoma skin cancer cases to 
other health effects is the same as they were in the estimates presented by Dr. Frazier of 
the Department of Energy. In this case, the total annual number of additional melanoma 
cases, melanoma fatalities, and cataracts would be 10, 3, and 1,800 respectively for a 
lower-bound estimate and 46, 9, and 4,600 respectively for an upper-bound estimate. This 
back-of-the-envelope calculation can in no way substitute for a thorough risk assessment, 
or for CASAC’s assessment and review of air quality criteria. But it casts substantial 
doubt on the Response’s finding that UV-B related health effects are negligible.   
It is useful to compare these estimates of UV-B related health effects with the 
respiratory h ealth effects estimated by EPA for the 1997 ozone standard. EPA reported 
that the ozone standard would avoid 40 hospital admissions in New York City among 
asthmatics.
39 For nine cities EPA estimated that the number of “outdoor” children 
experiencing temporary “moderate lung function decreases” would fall by 70,000 per 
year, while those experiencing temporary “large lung function decreases” would fall by 
about 40,000 per year.
40 In addition, it estimated that 14,000 children would avoid 
                                                 
36 See U.S. Environmental Protection Agency (1996a, vol III, p. 6-156). 
37 The Response discusses this issue without using any data other than unpublished internal staff analyses 
dating to 1994.  See U.S. Environmental Protection Agency (2001, p. 88). 
38 See U. S. Court of Appeals for the District of Columbia Circuit. (1999, Section III.B.) 
39 See U.S. Environmental Protection Agency (2001, p. 53). 




episodes of “moderate or severe pain on deep inspiration.”
41 EPA believes that these 
quantifiable respiratory health effects represent the measurable part of a pyramid of larger 
magnitude.
42 Notwithstanding the possibility of such a pyramid, we believe the available 
evidence suggests that the UV-B related health effects of reductions in ozone are large 
enough relative to these respiratory effects that they cannot be dismissed without further 
serious analysis.   
 
4. Conclusions and Recommendations  
While principled standard-setting requires more than science,
43 the Clean Air Act 
provides a significant role for science in establishing a sound basis for policy decisions.  
The Court’s decision that EPA must consider the benefits of ozone has left EPA with a 
Criteria Document that does not provide an adequate scientific basis for a new ozone 
standard. EPA’s Response to the Court’s decision creates an unwelcome precedent for 
curtailing scientific review prescribed by the Act.   
EPA’s actions to limit the scope of scientific review should not be rewarded. No 
public good is served by steering CASAC away from reviewing and assessing the science 
of UV-B screening and related testimony presented in CASAC hearings. This is 
especially true given the statement by EPA staff to CASAC that no policy decision had 
yet been made on the issue of whether UV-B screening effects would be considered by 
the Administrator.   
EPA’s actions since the Court of Appeals remand are equally troubling. In the 
twenty months after the Court’s decision, EPA made no effort t o update its risk 
assessments, develop new information on UV-B screening, or seek CASAC’s advice.  
The lack of scientific review means the  Response may harm public health. 
Reductions in respiratory ailments from the Response may not outweigh the increased 
risk of skin cancers and cataracts. We therefore make the following recommendations: 
•  EPA should expeditiously update its 1997 risk assessment of UV-B screening 
effects, correcting for deficiencies that have already been identified. In 
                                                 
41 See U.S. Environmental Protection Agency (1997d, p. 38865).  CASAC opinion generally held that 
single, short-term, and moderate health effects occurring in healthy individuals should not be considered 
adverse. See U.S. Environmental Protection Agency (1996b, Table V-5b).  
42 See U.S. Environmental Protection Agency (1997d, p. 38868). 




accordance with the court remand, EPA should prepare a supplement to the 
1997 Criteria Document that summarizes the literature on health effects from 
UV-B screening and the findings of all available risk assessments. EPA 
should also prepare an addendum to its staff paper addressing UV-B 
screening.   
•  EPA should seek scientific advice from CASAC about the magnitude of the 
beneficial effects of ozone and the most appropriate standard given such 
effects. To develop this advice, CASAC should convene an appropriate 
subcommittee that includes several experts in the scientific fields addressed in 
the supplement to the Criteria Document as well as experts familiar with the 
respiratory health fields addressed in the 1997 criteria document. This team 
should:  
o  review the Criteria Document s upplement that, together with the 
original criteria document, summarizes all identifiable effects;  
o  review all draft risk assessments related to UV-B screening, including 
an updated version of EPA’s 1997 assessment, other risk assessments 
in the record, and available published literature;  
o  recommend whether EPA should quantify given health effects; 
o  review revisions to EPA’s staff paper. 
Finally, CASAC should advise EPA about the appropriate form and level of 
the standard, taking account of both adverse and favorable effects of ozone.  
•  Using the CASAC reviews, EPA should propose a response to the remand and 
develop a final standard in light of public comment about its proposal.  
These recommendations are unlikely to delay emissions controls because EPA 
already has to respond to the Supreme Court’s decision on implementation.
44 In addition 
the Supreme Court said it remains for the Court of Appeals to dispose of other 
challenges, including, presumably questions about whether the revised air quality 
standards are arbitrary and capricious.
45 
                                                 
44 See U.S. Supreme Court (2001). 




If EPA followed these recommendations, it would honor its own prior 
commitments to transparent and consistent risk assessment and peer-review. EPA’s 
recent policy on risk “calls for a transparent process and [risk characterization] products 
that are clear, consistent and reasonable.”
46  The principle underlying EPA’s new peer-
review policy is that “all major scientific and technical work-products used in decision 
makings will be peer-reviewed.”
47  
The potential tradeoff between UV-B screening and respiratory health effects 
presents the EPA Administrator with a novel challenge in setting the air quality standard 
for ozone. That decision needs to reflect the best possible science.       
                                                 
46 See U.S. Environmental Protection Agency (2000b, p. 1). 
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